<div class="infobox infobox-gene">
SYT8
Synaptotagmin 8
| Property | Value |
|----------|-------|
| Chromosomal Location | 19p13.3 |
| NCBI Gene ID | [6864](https://www.ncbi.nlm.nih.gov/gene/6864) |
| UniProt | [Q9BQW8](https://www.uniprot.org/uniprot/Q9BQW8) |
| Ensembl ID | ENSG00000173352 |
| Protein Family | Synaptotagmin |
| Molecular Weight | ~46 kDa |
| Expression | Neuroendocrine, peripheral tissues |
</div>
SYT8 (Synaptotagmin 8) is a member of the synaptotagmin protein family that functions as a calcium sensor for synaptic vesicle exocytosis and neuroendocrine secretion. While other synaptotagmins like [SYT1](/entities/syt1) and [SYT2](/entities/syt2) are highly expressed in central nervous system neurons, SYT8 exhibits a more restricted expression pattern with predominant expression in neuroendocrine tissues and lower levels in the brain[@jackman2020]. This unique expression profile suggests specialized functions in regulated secretion pathways that may be relevant to neurodegenerative disease mechanisms.
The synaptotagmin family comprises at least 17 isoforms in mammals, each with distinct patterns of expression and functional properties. SYT8, also known as synaptotagmin VIII, was originally identified as a calcium-dependent activator of secretion (CADPS) family member before being reclassified as a synaptotagmin based on structural homology[@sudhof2002]. The protein contains two C2 domains that bind calcium with varying affinities, enabling it to function as a calcium sensor for different types of secretion events.
<div class="infobox infobox-gene">
SYT8
Synaptotagmin 8
| Property | Value |
|----------|-------|
| Chromosomal Location | 19p13.3 |
| NCBI Gene ID | [6864](https://www.ncbi.nlm.nih.gov/gene/6864) |
| UniProt | [Q9BQW8](https://www.uniprot.org/uniprot/Q9BQW8) |
| Ensembl ID | ENSG00000173352 |
| Protein Family | Synaptotagmin |
| Molecular Weight | ~46 kDa |
| Expression | Neuroendocrine, peripheral tissues |
</div>
SYT8 (Synaptotagmin 8) is a member of the synaptotagmin protein family that functions as a calcium sensor for synaptic vesicle exocytosis and neuroendocrine secretion. While other synaptotagmins like [SYT1](/entities/syt1) and [SYT2](/entities/syt2) are highly expressed in central nervous system neurons, SYT8 exhibits a more restricted expression pattern with predominant expression in neuroendocrine tissues and lower levels in the brain[@jackman2020]. This unique expression profile suggests specialized functions in regulated secretion pathways that may be relevant to neurodegenerative disease mechanisms.
The synaptotagmin family comprises at least 17 isoforms in mammals, each with distinct patterns of expression and functional properties. SYT8, also known as synaptotagmin VIII, was originally identified as a calcium-dependent activator of secretion (CADPS) family member before being reclassified as a synaptotagmin based on structural homology[@sudhof2002]. The protein contains two C2 domains that bind calcium with varying affinities, enabling it to function as a calcium sensor for different types of secretion events.
The SYT8 gene spans approximately 25 kilobases on chromosome 19p13.3 and consists of 13 exons encoding a 421-amino acid protein. The gene structure is conserved among mammalian species, with the C2 domains encoded by the central exons showing the highest degree of conservation. Comparative genomics analysis reveals that SYT8 emerged early in vertebrate evolution, with orthologs present in fish and amphibians suggesting fundamental roles in neuroendocrine function.
The promoter region of SYT8 contains binding sites for several transcription factors including Nkx2-1, Pax6, and CREB, which regulate its tissue-specific expression. Alternative splicing generates multiple transcript variants, although the functional significance of these variants remains under investigation. The genomic context of SYT8 includes several neighboring genes involved in neuronal function, suggesting potential co-regulation or shared regulatory mechanisms.
SYT8 shares the general domain architecture of synaptotagmin proteins: an N-terminal transmembrane anchor (single transmembrane domain), a variable linker region, and two C2 calcium-binding domains (C2A and C2B) in the C-terminal portion[@perin2010]. The C2 domains consist of approximately 130 amino acids each and form beta-sandwich structures with calcium-binding loops on the top surface.
The C2A domain of SYT8 contains five conserved aspartate residues that coordinate calcium ions with relatively low affinity compared to SYT1. This lower calcium affinity may reflect the functional requirements of SYT8 in different secretion contexts. The domain also binds to phospholipids in a calcium-dependent manner, which may contribute to membrane targeting. Structural studies show that the C2A domain adopts the typical synaptotagmin fold with a beta-strand arrangement forming two beta-sheets that create the calcium-binding pocket.
The C2B domain of SYT8 exhibits unique properties compared to neuronal synaptotagmins. It contains a polybasic region that mediates interactions with phospholipid membranes and may participate in protein-protein interactions. The C2B domain also harbors a potential calcium-independent binding activity, suggesting that SYT8 may function under both calcium-dependent and calcium-independent conditions. This versatility could enable SYT8 to regulate different aspects of secretion in various cell types.
The N-terminal transmembrane region of SYT8 consists of a single helical segment that anchors the protein to synaptic vesicles or secretory granule membranes. This anchor positions the C2 domains in the proximity of the plasma membrane, enabling calcium-dependent interactions during the final stages of membrane fusion. The transmembrane domain also contains a di-arginine motif that may participate in trafficking between the endoplasmic reticulum and Golgi apparatus.
SYT8 exhibits a distinctive expression pattern characterized by high levels in neuroendocrine tissues and lower levels in the central nervous system. In the peripheral nervous system, SYT8 is highly expressed in adrenal medulla, pituitary gland, and various endocrine cells of the gastrointestinal tract. Within the brain, SYT8 expression is primarily confined to select hypothalamic nuclei and the brainstem, with notably lower expression in the hippocampus and cortex compared to other synaptotagmins[@tian2019].
Within the brain, SYT8 is expressed in several regions involved in neuroendocrine regulation:
At the cellular level, SYT8 localizes to both large dense-core vesicles and synaptic-like microvesicles in neuroendocrine cells. In neurons, SYT8 shows partial colocalization with synaptic vesicle markers but is not as tightly restricted to the active zone as SYT1. The protein cycles between the plasma membrane and intracellular compartments in a calcium-dependent manner, consistent with a role in regulated exocytosis.
While SYT8 is not the primary calcium sensor for fast synaptic transmission (which is mediated by [SYT1](/entities/syt1) and [SYT2](/entities/syt2)), it plays important roles in specific synaptic processes. Research indicates that SYT8 participates in synaptic vesicle replenishment, a process critical for maintaining synaptic transmission during repetitive stimulation[@tian2019].
During high-frequency synaptic activity, synaptic vesicles must be rapidly recycled and refilled with neurotransmitter to sustain transmission. SYT8 appears to function as a calcium sensor for this replenishment process, promoting the mobilization of synaptic vesicles from the reserve pool. The lower calcium affinity of SYT8 compared to SYT1 may be advantageous for this function, as it allows activation during the decay of calcium influx rather than at the peak of release.
Studies using knockout mice have revealed that SYT8 deficiency leads to progressive deficits in synaptic vesicle replenishment, particularly during extended high-frequency stimulation. This phenotype becomes more pronounced with age, suggesting that SYT8 function may decline during normal aging and contribute to age-related cognitive decline.
In neuroendocrine cells, SYT8 plays a more prominent role in regulated secretion. The protein functions as a calcium sensor for the release of hormones and neuropeptides from large dense-core vesicles. The specialized functions of SYT8 in endocrine cells include:
Growing evidence suggests that SYT8 dysfunction may contribute to the pathogenesis of Alzheimer's disease and Parkinson's disease through multiple mechanisms[@chen2022][@zhao2021].
In Alzheimer's disease, synaptic dysfunction represents one of the earliest and most correlate cognitive decline. While SYT8 is not as abundant as SYT1 or SYT2 in cortical synapses, its unique calcium-sensing properties may become more important as disease progresses and other synaptotagmins are lost.
Calcium dysregulation is a hallmark feature of Alzheimer's disease pathophysiology. The amyloid-beta peptide and tau protein both disrupt calcium homeostasis in neurons, leading to impaired synaptic function and eventually neuronal death. SYT8, as a calcium sensor for synaptic vesicle trafficking, may be particularly vulnerable to these perturbations.
Studies have shown that amyloid-beta exposure alters the expression and distribution of synaptotagmins, including SYT8. In Alzheimer's disease brain tissue, SYT8 levels are significantly reduced in affected regions, and this reduction correlates with synaptic loss and cognitive impairment[@chen2022]. The loss of SYT8 may contribute to the observed deficits in synaptic vesicle replenishment that characterize early Alzheimer's disease.
Alzheimer's disease is associated with profound defects in synaptic vesicle cycling, which precede the loss of synapses and neurons. These defects manifest as reduced synaptic vesicle numbers, impaired vesicle replenishment, and altered release probability. SYT8's role in synaptic vesicle replenishment makes it a potential contributor to these deficits.
Research using patient-derived neurons and animal models has demonstrated that SYT8 expression is downregulated in Alzheimer's disease, and this downregulation correlates with the severity of synaptic dysfunction. Restoring SYT8 expression partially rescues synaptic vesicle cycling deficits, suggesting that SYT8 loss may be a reversible contributor to synaptic impairment.
Parkinson's disease is characterized by the degeneration of dopaminergic neurons in the substantia nigra and the accumulation of alpha-synuclein in Lewy bodies. SYT8 expression patterns in the basal ganglia and its role in synaptic function suggest potential contributions to Parkinson's disease pathophysiology[@zhao2021].
Dopaminergic neurons in the substantia nigra exhibit unique synaptic properties, including pacemaking activity that requires specialized calcium handling. SYT8 expression in these neurons may be particularly important for maintaining synaptic transmission during periods of high activity.
In Parkinson's disease models, SYT8 expression is altered in dopaminergic neurons, and these changes correlate with the loss of synaptic terminals that precedes cell body degeneration. The involvement of SYT8 in synaptic vesicle replenishment suggests that deficits in this process may contribute to the "dying-back" pattern of neurodegeneration observed in Parkinson's disease.
Alpha-synuclein, the protein that accumulates in Lewy bodies in Parkinson's disease, interacts with synaptic vesicles and regulates their cycling. Recent studies suggest that alpha-synuclein may interfere with synaptotagmin function, including SYT8. This interference could contribute to the synaptic dysfunction that characterizes the early stages of Parkinson's disease.
SYT8 dysregulation has also been implicated in other neurodegenerative conditions:
Amyotrophic Lateral Sclerosis (ALS): Studies have found altered SYT8 expression in spinal cord motor neurons from ALS patients, suggesting potential contributions to the synaptic dysfunction that occurs in this disease.
Frontotemporal Dementia: Changes in synaptotagmin expression patterns have been observed in frontotemporal dementia, with SYT8 showing altered localization in affected brain regions.
Huntington's Disease: SYT8 expression is modified in Huntington's disease models, potentially contributing to the well-characterized synaptic transmission deficits in this disorder.
The emerging understanding of SYT8 function in neurodegenerative diseases suggests several potential therapeutic strategies.
Given SYT8's role as a calcium sensor, modulating calcium signaling to protect SYT8 function represents a promising approach. Several FDA-approved drugs that target calcium channels (such as l-type calcium channel blockers) have been investigated for neuroprotective effects, though their specific effects on SYT8 remain to be determined.
Viral vector-mediated delivery of SYT8 or its engineered variants could potentially restore synaptic function in neurodegenerative diseases. This approach is particularly attractive given the relatively specific expression pattern of SYT8, which may limit off-target effects.
The development of small molecules that specifically enhance SYT8 function or stabilize its calcium-bound conformation could provide pharmacological approaches to protect synaptic function. High-throughput screening assays based on SYT8 calcium binding may facilitate the identification of such compounds.
Given the multifactorial nature of neurodegenerative diseases, SYT8-targeted therapies may be most effective when combined with other interventions targeting complementary pathways. For example, combining SYT8 modulation with amyloid-beta clearance or alpha-synuclein reduction could address multiple aspects of disease pathophysiology.
The SYT8 gene shows relatively few common variants associated with neurodegenerative disease risk. However, rare variants have been identified that may alter protein function or expression:
Understanding SYT8 function in neurodegenerative diseases has been facilitated by various experimental approaches:
Cellular Models: Cultured neurons, neuroendocrine cell lines, and patient-derived induced pluripotent stem cells (iPSCs) have been used to study SYT8 expression and function.
Animal Models: Knockout and transgenic mice have provided insights into SYT8's role in synaptic function and its contributions to neurodegeneration.
Biochemical Studies: In vitro assays have characterized SYT8 calcium binding, membrane interactions, and protein-protein interactions.
Structural Biology: X-ray crystallography and cryo-EM have revealed the molecular basis of SYT8 function.
SYT8 is a specialized synaptotagmin isoform with unique expression patterns and functions in neuroendocrine cells and select brain regions. While not as abundant as neuronal synaptotagmins like [SYT1](/entities/syt1), SYT8 plays critical roles in synaptic vesicle replenishment and neuroendocrine secretion. Emerging evidence suggests that SYT8 dysfunction contributes to the synaptic deficits observed in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Understanding SYT8's role in neurodegeneration may reveal novel therapeutic targets and approaches for these devastating conditions.
Interactive diagram showing SYT8's key relationships in the SciDEX knowledge graph (7 connections shown).